diabetes glp 1 agonist Glucagon-like peptide-1 GLP-1 receptor agonists are increasingly
Description
doi: 10.1016/j.phrs.2022.106320 [DOI] [PubMed] [Google Scholar] 74
The real question is whether this space will mature into a legitimate, responsible arm of obesity medicine or be dismissed as a chaotic market of pill mills
Several factors contribute to this common misconception
For broader regulatory context, see FDA Peptide Reclassification 2026: What It Means for Canadian Researchers
